Mathaes Roman, Mahler Hanns-Christian, Roggo Yves, Huwyler Joerg, Eder Juergen, Fritsch Kamila, Posset Tobias, Mohl Silke, Streubel Alexander
Pharmaceutical Development & Supplies, Technical Development Biologics Europe, F. Hoffmann-La Roche Ltd., Basel, Switzerland; Current address: Drug Product Services, Lonza AG, Basel, Switzerland
Pharmaceutical Development & Supplies, Technical Development Biologics Europe, F. Hoffmann-La Roche Ltd., Basel, Switzerland; Current address: Drug Product Services, Lonza AG, Basel, Switzerland.
PDA J Pharm Sci Technol. 2016 Mar-Apr;70(2):109-19. doi: 10.5731/pdajpst.2015.005918. Epub 2016 Jan 21.
Capping equipment used in good manufacturing practice manufacturing features different designs and a variety of adjustable process parameters. The overall capping result is a complex interplay of the different capping process parameters and is insufficiently described in literature. It remains poorly studied how the different capping equipment designs and capping equipment process parameters (e.g., pre-compression force, capping plate height, turntable rotating speed) contribute to the final residual seal force of a sealed container closure system and its relation to container closure integrity and other drug product quality parameters. Stopper compression measured by computer tomography correlated to residual seal force measurements.In our studies, we used different container closure system configurations from different good manufacturing practice drug product fill & finish facilities to investigate the influence of differences in primary packaging, that is, vial size and rubber stopper design on the capping process and the capped drug product. In addition, we compared two large-scale good manufacturing practice manufacturing capping equipment and different capping equipment settings and their impact on product quality and integrity, as determined by residual seal force.The capping plate to plunger distance had a major influence on the obtained residual seal force values of a sealed vial, whereas the capping pre-compression force and the turntable rotation speed showed only a minor influence on the residual seal force of a sealed vial. Capping process parameters could not easily be transferred from capping equipment of different manufacturers. However, the residual seal force tester did provide a valuable tool to compare capping performance of different capping equipment. No vial showed any leakage greater than 10(-8)mbar L/s as measured by a helium mass spectrometry system, suggesting that container closure integrity was warranted in the residual seal force range tested for the tested container closure systems.
Capping equipment used in good manufacturing practice manufacturing features different designs and a variety of adjustable process parameters. The overall capping result is a complex interplay of the different capping process parameters and is insufficiently described in the literature. It remains poorly studied how the different capping equipment designs and capping equipment process parameters contribute to the final capping result.In this study, we used different container closure system configurations from different good manufacturing process drug product fill & finish facilities to investigate the influence of the vial size and the rubber stopper design on the capping process. In addition, we compared two examples of large-scale good manufacturing process capping equipment and different capping equipment settings and their impact on product quality and integrity, as determined by residual seal force.
药品生产质量管理规范(GMP)生产中使用的封盖设备具有不同的设计和各种可调节的工艺参数。封盖的总体结果是不同封盖工艺参数之间复杂的相互作用,而相关文献对此描述并不充分。目前对于不同的封盖设备设计和封盖设备工艺参数(例如预压力、封盖板高度、转盘转速)如何影响密封容器封闭系统的最终残余密封力,以及其与容器密封完整性和其他药品质量参数之间的关系,仍研究不足。通过计算机断层扫描测量的塞子压缩与残余密封力测量相关。在我们的研究中,我们使用了来自不同药品生产质量管理规范药品灌装和包装设施的不同容器封闭系统配置,以研究一级包装差异(即小瓶尺寸和橡胶塞设计)对封盖过程和封好的药品的影响。此外,我们比较了两种大规模药品生产质量管理规范生产的封盖设备以及不同的封盖设备设置,及其对产品质量和完整性的影响(通过残余密封力来确定)。封盖板与柱塞的距离对密封小瓶获得的残余密封力值有重大影响,而封盖预压力和转盘转速对密封小瓶的残余密封力影响较小。封盖工艺参数不易从不同制造商的封盖设备转移。然而,残余密封力测试仪确实为比较不同封盖设备的封盖性能提供了一个有价值的工具。通过氦质谱系统测量,没有小瓶显示出大于10^(-8)毫巴·升/秒的泄漏,这表明在所测试的容器封闭系统的残余密封力范围内,容器密封完整性得到了保证。
药品生产质量管理规范生产中使用的封盖设备具有不同的设计和各种可调节的工艺参数。封盖的总体结果是不同封盖工艺参数之间复杂的相互作用,而相关文献对此描述并不充分。目前对于不同的封盖设备设计和封盖设备工艺参数如何影响最终封盖结果,仍研究不足。在本研究中,我们使用了来自不同药品生产工艺药品灌装和包装设施的不同容器封闭系统配置,以研究小瓶尺寸和橡胶塞设计对封盖过程的影响。此外,我们比较了两个大规模药品生产工艺封盖设备的示例以及不同的封盖设备设置,及其对产品质量和完整性的影响(通过残余密封力来确定)。